![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Demonstrates Comparable Efficacy and Favorable
Tolerability to Efavirenz/Emtricitabine/Tenofovir DF and to Ritonavir-boosted Atazanavir Plus Emtricitabine/Tenofovir
DF in Patients ≥50 Years at Week 96
|
|
|
Studies 102 and 103 - Age Sub-analysis
Reported by Jules Levin
53rd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Denver, CO, USA
Sept 10-13, 2013
J Gallant1, D Hardy2, F Bredeek3, K Workowski4, W Towner5, L Dau6, H Liu6, J Curley6, M Rhee6, D Piontkowsky6, J Szwarcberg6
1Southwest CARE Center, Santa Fe, NM, 2David Geffen School of Medicine-UCLA, Los Angeles, CA, 3Metropolis Med Group, San Francisco, CA, 4Emory Univ, Atlanta, GA, 5Kaiser Permanente, Los Angeles, CA, 6Gilead Sciences, Foster City, CA
![ICAAC1.gif](../images/091613/091613-14/ICAAC1.gif)
![ICAAC2.gif](../images/091613/091613-14/ICAAC2.gif)
![ICAAC3.gif](../images/091613/091613-14/ICAAC3.gif)
![ICAAC4.gif](../images/091613/091613-14/ICAAC4.gif)
![ICAAC5.gif](../images/091613/091613-14/ICAAC5.gif)
![ICAAC6.gif](../images/091613/091613-14/ICAAC6.gif)
![ICAAC7.gif](../images/091613/091613-14/ICAAC7.gif)
![ICAAC8.gif](../images/091613/091613-14/ICAAC8.gif)
![ICAAC9.gif](../images/091613/091613-14/ICAAC9.gif)
![ICAAC10.gif](../images/091613/091613-14/ICAAC10.gif)
![ICAAC11.gif](../images/091613/091613-14/ICAAC11.gif)
![ICAAC12.gif](../images/091613/091613-14/ICAAC12.gif)
![ICAAC13.gif](../images/091613/091613-14/ICAAC13.gif)
![ICAAC14.gif](../images/091613/091613-14/ICAAC14.gif)
![ICAAC15.gif](../images/091613/091613-14/ICAAC15.gif)
![ICAAC16.gif](../images/091613/091613-14/ICAAC16.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|